Isotretinoin Therapy Guidelines

Indications and Dosing

The American Academy of Dermatology recommends isotretinoin for severe nodular acne, and for moderate acne that is treatment-resistant, quick-relapsing after antibiotics, or causing physical scarring or psychosocial distress 1, 2
Start at 0.5 mg/kg/day for the first month, then increase to 1.0 mg/kg/day for severe acne 3
Target cumulative dose of 120-150 mg/kg to minimize relapse rates 1, 3
Standard treatment duration is 15-20 weeks depending on cumulative dose target 3
Continue treatment for at least 2 months after achieving clear skin to reduce relapse 3
Low-dose isotretinoin (0.25-0.4 mg/kg/day or 20 mg/day) is effective for moderate or treatment-resistant acne with significantly fewer side effects 1, 3

The American Academy of Dermatology guidelines recommend monitoring liver function tests and fasting lipids at baseline and again until response to treatment is established 1
Monitor AST and ALT at baseline and monthly during treatment 3
Abnormal liver function tests occur in 0.8-10.4% of patients 1
If transaminases elevate to 3 times upper normal limit, discontinue isotretinoin 4
Monitor fasting lipid panel at baseline and monthly 3
Abnormal triglycerides occur in 7.1-39.0% of patients 1
Abnormal cholesterol occurs in 6.8-27.2% of patients 1
If triglycerides exceed 800 mg/dL, discontinue isotretinoin immediately and refer urgently to lipidology due to pancreatitis risk 4

Monthly pregnancy tests required for all patients with pregnancy potential 2, 3
Monitor for depression, mood changes, anxiety at each visit 2
While population-based studies show no increased risk of neuropsychiatric conditions, individual case reports suggest possible causal association 1

After achieving cumulative dose of 120-150 mg/kg, complete therapy 1, 3
Continue at least 2 months after no evidence of disease activity 3
Higher cumulative doses (≥220 mg/kg) associated with lower relapse rates, particularly in patients <16 years old 3
Stop isotretinoin immediately if transaminases >3 times upper normal limit, triglycerides approaching or exceeding 800-1000 mg/dL, signs/symptoms of pancreatitis, severe skin reactions, signs of pseudotumor cerebri, depression, mood disturbance, psychosis, or aggression develops, pregnancy, or signs of inflammatory bowel disease 2, 4

The 2024 American Academy of Dermatology (AAD) guideline recommends a cumulative isotretinoin dose of 120–150 mg/kg to minimize relapse rates, with a typical treatment course lasting 15–20 weeks. 5

The AAD guideline states that a low‑dose regimen (0.25–0.4 mg/kg/day, e.g., ~15–25 mg/day for a 60 kg patient) administered for more than 6 months is effective for moderate or treatment‑resistant acne, provides significantly fewer side effects, and yields relapse rates comparable to standard dosing. 5

For long‑term maintenance after a full isotretinoin course, the AAD guideline recommends topical retinoids (adapalene or tretinoin) combined with benzoyl peroxide. 5
In female patients, the AAD guideline recommends hormonal therapy (combined oral contraceptives or spironolactone) as a maintenance option. 5

The AAD guideline advises patients to discard any leftover isotretinoin tablets and consult their dermatologist to arrange either a properly monitored second course (if acne remains severe after the required observation period) or transition to the above long‑term maintenance therapies. 5